U.S., Aug. 13 -- ClinicalTrials.gov registry received information related to the study (NCT07761546) titled 'AIM-TEST: Microbiome-Targeted Nutrition for Functional Secondary Hypogonadism' on Aug. 06.
Brief Summary: AIM-TEST is a randomized, double-blind, placebo-controlled clinical trial evaluating whether an AI-guided, microbiome-targeted nutritional intervention can increase the body's own testosterone production in men aged 30-65 years with symptomatic, biochemically confirmed functional secondary hypogonadism.
Functional secondary hypogonadism is characterized by symptoms of testosterone deficiency together with repeatedly low morning testosterone levels and low or inappropriately normal gonadotropin levels, without evidence of primar...